Neurology clinical trials recruiting in New York

30 recruiting neurology trials match in New York. Showing 20.

• TSC Biosample Repository and Natural History DatabaseRecruiting

  N/A · National Tuberous Sclerosis Association · New York, New York

• Virtual Cycling Environments for Persons With Parkinson DiseaseRecruiting

  N/A · Rutgers, The State University of New Jersey · Newark, New Jersey

• Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruiting

  Phase 3 · Pfizer · Amherst, New York

• A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigraineRecruiting

  Phase 3 · Merz Therapeutics GmbH · Amherst, New York

• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineRecruiting

  Phase 3 · Kallyope Inc. · Amherst, New York

• A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting

  Phase 2 / Phase 3 · Washington University School of Medicine · New York, New York

• NYSCF Scientific Discovery BiobankRecruiting

  N/A · New York Stem Cell Foundation Research Institute · New York, New York

• Eccentric Exercise and Fatigue in Multiple SclerosisRecruiting

  N/A · Hunter College of City University of New York · New York, New York

• Speech Learning and Speech Production in Parkinson's DiseaseRecruiting

  N/A · State University of New York at Buffalo · Buffalo, New York

• Parkinson's Foundation PD GENEration Genetic RegistryRecruiting

  N/A · Parkinson's Foundation · New York, New York

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of MigraineRecruiting

  Phase 3 · Kallyope Inc. · Amherst, New York

• Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental DisordersRecruiting

  N/A · Southwest Autism Research & Resource Center · Brooklyn, New York

• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantRecruiting

  Phase 3 · Eidos Therapeutics, a BridgeBio company · New York, New York

• Effect of Cooling on Balance Performance in Multiple SclerosisRecruiting

  N/A · Hunter College of City University of New York · New York, New York

• An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeRecruiting

  Phase 3 · Epygenix · New York, New York

• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)Recruiting

  Phase 3 · Bristol-Myers Squibb · Albany, New York

• A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Mineola, New York

• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesRecruiting

  Phase 3 · Hoffmann-La Roche · Laurelton, New York

• A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting

  Phase 2 / Phase 3 · Washington University School of Medicine · New York, New York

• Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease SubjectsRecruiting

  N/A · New York Institute of Technology · Old Westbury, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.